Medical Developments International Limited
Medical Developments International Limited
- P/E ratio
- 75.89
Your view on MVP.AX
Overview
What the company does, where it operates, and who runs it.
About Medical Developments International Limited
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Brent MacGregor
- Headquarters
- 4 Caribbean Drive, Scoresby, VIC, AU
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Brent MacGregor
- Headquarters
- 4 Caribbean Drive, Scoresby, VIC, AU
Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care.
Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD).
Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus.
Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Medical Developments International Limited from FRC's valuation model, read against the market price. MVP.AX last traded at AUD 0.49, 75.9× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Medical Developments International Limited. Starting points for Medical Developments International Limited: P/E 75.9, EPS AUD 0.0056, beta 1.39 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Medical Developments International Limited. Medical Developments International Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Medical Developments International Limited. Trailing twelve-month EPS for Medical Developments International Limited stands at AUD 0.0056. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.00 | −AUD 0.01 | AUD 0.01 | AUD 0.04 |
| Lowest estimate | AUD 0.00 | −AUD 0.01 | −AUD 0.00 | AUD 0.02 |
| Highest estimate | AUD 0.00 | −AUD 0.01 | AUD 0.03 | AUD 0.05 |
| Number of analysts | 0 | 1 | 2 | 2 |
| A year ago | −AUD 0.071 | −AUD 0.10 | AUD 0.011 | — |
| Growth vs a year ago | — | +86.0% | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 19.69M | AUD 21.60M | AUD 45.95M | AUD 51.30M |
| Lowest estimate | AUD 19.69M | AUD 21.60M | AUD 45.70M | AUD 51.20M |
| Highest estimate | AUD 19.69M | AUD 21.60M | AUD 46.20M | AUD 51.40M |
| Number of analysts | 1 | 1 | 2 | 2 |
| A year ago | AUD 12.77M | AUD 18.41M | AUD 42.57M | — |
| Growth vs a year ago | +54.2% | +17.3% | +7.9% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Medical Developments International Limited. Medical Developments International Limited has reported as a listed company since 2003. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ATX.AXAmplia Therapeutics Limited | Healthcare | Biotechnology | — | ||
| CYC.AXCyclopharm Limited | Healthcare | Medical - Devices | — | ||
| GSS.AXGenetic Signatures Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IPD.AXImpediMed Limited | Healthcare | Medical - Devices | — | ||
| M7T.AXMach7 Technologies Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| MX1.AXMicro-X Limited | Healthcare | Medical - Devices | — | ||
| PCK.AXPainChek Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| APTX.TOApotex Health Corp. | Healthcare | TSX | $9.4B | ||
| AQSTAquestive Therapeutics, Inc. | Healthcare | NASDAQ | $475.1M | ||
| AQSZFAequus Pharmaceuticals Inc. | Healthcare | OTC | $652,561 | ||
| ARSUFFagron N.V. | Healthcare | OTC | $2.0B | ||
| ARYXARYx Therapeutics, Inc. | Healthcare | OTC | $16,731 | ||
| AUSAFAustralis Capital Inc. | Healthcare | OTC | $27,828 | ||
| AVCN.TOAvicanna Inc. | Healthcare | TSX | $11.8M | ||
| AVCNFAvicanna Inc. | Healthcare | OTC | $16.3M | ||
| AVNT.TOAvant Brands Inc. | Healthcare | TSX | $8.0M | ||
| AVTBFAvant Brands Inc. | Healthcare | OTC | $6.9M | ||
| AXRXAmexdrug Corporation | Healthcare | OTC | $33,882 | ||
| AYRWFAyr Wellness Inc. | Healthcare | OTC | $2.6M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Medical Developments International Limited. Coverage tracks Medical Developments International Limited within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Medical Developments International Limited.